TALS

Talaris Therapeutics (TALS)

Talaris Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:TALS

1 2 3 4 5 6 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/04/20	05 : 05	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:TALS	Talaris Therapeutics Inc
2024/04/20	05 : 04	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:TALS	Talaris Therapeutics Inc
2024/04/20	05 : 02	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:TALS	Talaris Therapeutics Inc
2024/03/20	06 : 10	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:TALS	Talaris Therapeutics Inc
2024/03/20	06 : 02	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:TALS	Talaris Therapeutics Inc
2024/03/19	20 : 09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TALS	Talaris Therapeutics Inc
2023/11/21	08 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TALS	Talaris Therapeutics Inc
2023/11/21	08 : 14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TALS	Talaris Therapeutics Inc
2023/11/07	06 : 30	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:TALS	Talaris Therapeutics Inc
2023/10/31	05 : 15	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:TALS	Talaris Therapeutics Inc
2023/10/28	06 : 17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TALS	Talaris Therapeutics Inc
2023/10/28	05 : 02	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:TALS	Talaris Therapeutics Inc
2023/10/27	06 : 34	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TALS	Talaris Therapeutics Inc
2023/10/27	06 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TALS	Talaris Therapeutics Inc
2023/10/27	05 : 46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TALS	Talaris Therapeutics Inc
2023/10/21	10 : 23	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:TALS	Talaris Therapeutics Inc
2023/10/18	06 : 47	GlobeNewswire Inc.	Talaris Therapeutics Announces Stockholder Approval of Merger with Tourmaline Bio	NASDAQ:TALS	Talaris Therapeutics Inc
2023/10/11	05 : 32	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:TALS	Talaris Therapeutics Inc
2023/10/11	05 : 30	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:TALS	Talaris Therapeutics Inc
2023/10/07	09 : 01	Dow Jones News	Stocks to Watch: Shift Technologies, Talaris Therapeutics, Lockheed Martin	NASDAQ:TALS	Talaris Therapeutics Inc
2023/10/07	06 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TALS	Talaris Therapeutics Inc
2023/10/07	06 : 27	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:TALS	Talaris Therapeutics Inc
2023/10/07	06 : 26	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TALS	Talaris Therapeutics Inc
2023/10/07	06 : 09	GlobeNewswire Inc.	Talaris Therapeutics Declares Special Dividend In Connection with Proposed Merger with Tourmaline Bio	NASDAQ:TALS	Talaris Therapeutics Inc
2023/10/04	21 : 30	GlobeNewswire Inc.	New York Blood Center Enterprises Acquires Commercial-Scale Cell & Gene Therapy Development and Manufacturing Facilities from Talaris Therapeutics	NASDAQ:TALS	Talaris Therapeutics Inc
2023/09/26	21 : 24	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:TALS	Talaris Therapeutics Inc
2023/09/26	21 : 21	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TALS	Talaris Therapeutics Inc
2023/09/15	19 : 31	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:TALS	Talaris Therapeutics Inc
2023/09/15	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:TALS	Talaris Therapeutics Inc
2023/09/14	05 : 28	Edgar (US Regulatory)	Form S-4/A - Registration of securities, business combinations: [Amend]	NASDAQ:TALS	Talaris Therapeutics Inc